Analyst firms · Oppenheimer · NOW
Oppenheimer NOW price target and rating history
ServiceNow Inc. (NOW) · Technology
Oppenheimer rates ServiceNow Inc. (NOW) Outperform with a $660 price target, as of its latest action on Jan 27, 2022. It has published 3 rating actions on NOW since August 2021, including 0 upgrades and 0 downgrades. Across 12 firms with a NOW price target in the last 12 months, the median target is $136.
- Current rating
- Outperform
- Price target
- $660
- Median target, all firms
- $136
- Actions on NOW
- 3
Oppenheimer price target on NOW
Every Oppenheimer rating on NOW
- Jan 27, 2022
- Oct 22, 2021
- Aug 20, 2021
How other firms rate NOW
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BMO Capital Markets | Outperform | $118 | Jul 23, 2026 |
| CLSA | Underperform | $72 | Jul 20, 2026 |
| Guggenheim | Buy | $125 | Jul 1, 2026 |
| BofA Securities | Buy | $130 | May 18, 2026 |
| Barclays | Overweight | $132 | Apr 23, 2026 |
| UBS | Neutral | $100 | Apr 10, 2026 |
| BNP Paribas Exane | Outperform | $140 | Mar 16, 2026 |
| Goldman Sachs | Buy | $205 | Jan 12, 2026 |
| Arete Research | Buy | $200 | Jan 6, 2026 |
| BTIG | Buy | $1,000 | Dec 17, 2025 |
| KeyBanc Capital Markets | Underweight | $775 | Dec 15, 2025 |
| Macquarie | Neutral | $860 | Nov 25, 2025 |
Questions about Oppenheimer and NOW
- What is Oppenheimer's price target for NOW?
- Oppenheimer's latest stated price target for ServiceNow Inc. (NOW) is $660, from its action on Jan 27, 2022.
- What is Oppenheimer's rating on NOW?
- Oppenheimer rates NOW Outperform, a bullish rating, as of Jan 27, 2022.
- When did Oppenheimer last change its view on NOW?
- On Jan 27, 2022, Oppenheimer cuts its price target to $660 from $775, keeps Outperform.
- How does Oppenheimer's NOW target compare with other analysts?
- Across 12 firms with a NOW price target in the last 12 months, the median target is $136.
More NOW rating histories
- BMO Capital Markets13
- Guggenheim6
- BofA Securities4
- Barclays4
- UBS4
- BNP Paribas Exane3
- KeyBanc Capital Markets5
- Morgan Stanley6
- Truist Securities4
- Needham4
- Jefferies3
- Canaccord Genuity3
- Mizuho4
- Piper Sandler4
- Stifel3
- RBC Capital Markets3
All Oppenheimer ratingsNOW news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.